Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative.

MetS and obesity status have independent, but differential, adverse associations with breast cancer receptor subtypes and breast cancer mortality risk. Both represent separate targets for breast cancer prediction and prevention strategies.